(Q34601561)

3 August 2017

In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin (English)

1 reference

3 August 2017

1

A L Barry

1 reference

3 August 2017

2

P C Fuchs

1 reference

PubMed ID

1906696

3 August 2017

language of work or name

English

0 references

publication date

1 May 1991

1 reference

Antimicrobial Agents and Chemotherapy

3 August 2017

1 reference

3 August 2017

35

1 reference

3 August 2017

955-960

1 reference

3 August 2017

5

1 reference

A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245135

In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245135

In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245135

In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245135

Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245135

In vitro activity of AT-4140 against clinical bacterial isolates

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245135

Antistaphylococcal activities of sparfloxacin (CI-978; AT-4140), ofloxacin, and ciprofloxacin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245135

Comparative in vitro activities of sparfloxacin (CI-978; AT-4140) and other antimicrobial agents against staphylococci, enterococci, and respiratory tract pathogens

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245135

In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245135

In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245135

In vitro activity of sparfloxacin (AT-4140, CI-978, PD 131501), a new quinolone antimicrobial agent

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245135

In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245135

Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245135

Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates

7 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1906696

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.35.5.955

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

PubMed ID

1906696